Arbutus Biopharma (ABUS) Receivables - Accured (2022 - 2026)
Arbutus Biopharma's (ABUS) quarterly Receivables - Accured came in at $300000.0 in Q1 2026, up 50.0% year-on-year from $200000.0 in Q1 2025, and little changed quarter-over-quarter from $300000.0 in Q4 2025.
Arbutus Biopharma (ABUS) Receivables - Accured (2022 - 2026) Analysis & Trends
Arbutus Biopharma has disclosed Receivables - Accured across 5 years of filings, most recently posting $300000.0 for Q1 2026.
- Receivables - Accured for Q1 2026 came in at $300000.0, up 50.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $300000.0 (up 50.0% YoY), and the FY2025 annual result was $300000.0, changed 0.0% from the prior year.
- Receivables - Accured came in at $300000.0 for Q1 2026 at Arbutus Biopharma, roughly flat from $300000.0 in the prior quarter.
- In the past five years, Receivables - Accured ranged from a high of $600000.0 in Q4 2022 to a low of $100000.0 in Q2 2025.
- The 5-year median for Receivables - Accured is $300000.0 (2024), against an average of $407142.9.
- Across the five-year window, Receivables - Accured sank 66.67% in 2025 and jumped 50.0% in 2026, its largest moves.
- Arbutus Biopharma's Receivables - Accured stood at $600000.0 in 2022, then changed by 0.0% to $600000.0 in 2023, then slumped by 50.0% to $300000.0 in 2024, then changed by 0.0% to $300000.0 in 2025, then changed by 0.0% to $300000.0 in 2026.
- The last three Receivables - Accured figures came in at $300000.0 (Q1 2026), $300000.0 (Q4 2025), and $300000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acc. Int. Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arbutus Biopharma | 882.62 Mn | 882.62 Mn | - | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 600,000.00 |
| Dec 31, 2023 | 600,000.00 |